Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

Test: Critical Congenital Heart Disease Gene Panel

Maximum Days to Obtain Report: 10-14 days

What are the prerequisites for the test Critical Congenital Heart Disease Gene Panel

  • Written consent for genetic testing
  • Requisition form completed with relevant clinical information
  • Specimen requirements: Whole blood in a lavender top (EDTA) tube
  • Minimum volume of 3 mL of blood
  • Properly labeled specimen with patient name, date of birth, and collection date
  • Shipping requirements: Specimen must be shipped at room temperature and received within 72 hours of collection

What are the measure values for the test Critical Congenital Heart Disease Gene Panel

  • Gene Panel Name: Critical Congenital Heart Disease Gene Panel
  • Number of Genes Included: 50
  • Test Type: Next-Generation Sequencing (NGS)
  • Methodology: Polymerase Chain Reaction (PCR) followed by NGS
  • Specimen Required: 3-5 mL of blood in EDTA tube

What does this test Critical Congenital Heart Disease Gene Panel identify?

  • Critical Congenital Heart Disease Gene Panel identifies mutations in specific genes that are associated with critical congenital heart diseases.
  • These genes play a crucial role in the development and function of the heart, and mutations in these genes can lead to serious heart defects.
  • The panel tests for mutations in genes such as MYH6, NKX2-5, and GATA4, among others, which are known to be linked to critical congenital heart diseases.
  • Identifying these mutations can help healthcare providers diagnose critical congenital heart diseases early on, allowing for timely interventions and treatments.

Why is this test Critical Congenital Heart Disease Gene Panel taken?

  1. This test is taken to screen for genetic mutations associated with Critical Congenital Heart Disease (CCHD).
  2. It helps in identifying individuals who may be at risk for developing CCHD, allowing for early intervention and treatment.
  3. The results of the test can provide valuable information for healthcare providers to personalize patient care and management.
  4. Early detection of genetic mutations associated with CCHD can help in preventing potentially life-threatening complications.

No FAQs available.

Customer Google Rating